Connect Biopharma Holdings Total Liabilities Growth & History (CNTB)

Connect Biopharma Holdings's total liabilities was $14.1M for fiscal 2025.

View full Connect Biopharma Holdings company overview

Connect Biopharma Holdings annual total liabilities history

Connect Biopharma Holdings annual total liabilities

Fiscal yearPeriod endedTotal liabilitiesChangeGrowth
20252025-12-31$14.1M$5.0M+54.58%
20242024-12-31$9.1M−$16.8M−64.77%
20232023-12-31$25.9M$9.4M+56.64%
20222022-12-31$16.5M−$2.3M−12.10%
20212021-12-31$18.8M

Connect Biopharma Holdings total liabilities trends

Between the periods ended 2021-12-31 and 2025-12-31, Connect Biopharma Holdings's total liabilities decreased from $18.8M to $14.1M, a change of −$4.7M. The latest reported quarter, Q2 2026, shows $16.6M.

About the metric

What total liabilities mean

Total liabilities are all obligations reported on a company’s balance sheet, including debt, accounts payable, accrued expenses, deferred revenue, lease liabilities, and other current and long-term obligations.

Calculation and source

SEC-reported and calculated total liabilities

TickerStat uses total liabilities reported in company SEC filings when available. Otherwise, it calculates total liabilities as aligned total assets minus total equity for the same balance-sheet date. Total liabilities should not be confused with interest-bearing debt. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Connect Biopharma Holdings source filings ↗

Community posts

It’s quiet here.

No posts about CNTB yet. Start the conversation.

Write the first post